[go: up one dir, main page]

HRP20100029T1 - Novi kristalinični anhidrid s antiholinergičkim učinkom - Google Patents

Novi kristalinični anhidrid s antiholinergičkim učinkom Download PDF

Info

Publication number
HRP20100029T1
HRP20100029T1 HR20100029T HRP20100029T HRP20100029T1 HR P20100029 T1 HRP20100029 T1 HR P20100029T1 HR 20100029 T HR20100029 T HR 20100029T HR P20100029 T HRP20100029 T HR P20100029T HR P20100029 T1 HRP20100029 T1 HR P20100029T1
Authority
HR
Croatia
Prior art keywords
cyclodextrin
tiotropium bromide
medicine
anhydride
crystalline
Prior art date
Application number
HR20100029T
Other languages
English (en)
Croatian (hr)
Inventor
Pfrengle Waldemar
Sieger Peter
Original Assignee
Boehringer Ingelheim International Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34530662&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20100029(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim International Gmbh filed Critical Boehringer Ingelheim International Gmbh
Publication of HRP20100029T1 publication Critical patent/HRP20100029T1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HR20100029T 2003-11-03 2004-10-29 Novi kristalinični anhidrid s antiholinergičkim učinkom HRP20100029T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03025077 2003-11-03
PCT/EP2004/012269 WO2005042527A1 (de) 2003-11-03 2004-10-29 Neues kristallines anhydrat mit anticholinerger wirksamkeit

Publications (1)

Publication Number Publication Date
HRP20100029T1 true HRP20100029T1 (hr) 2010-02-28

Family

ID=34530662

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20100029T HRP20100029T1 (hr) 2003-11-03 2004-10-29 Novi kristalinični anhidrid s antiholinergičkim učinkom

Country Status (33)

Country Link
EP (1) EP1682542B1 (uk)
JP (1) JP4553902B2 (uk)
KR (2) KR101313904B1 (uk)
CN (1) CN100509809C (uk)
AR (1) AR046319A1 (uk)
AT (1) ATE453641T1 (uk)
AU (1) AU2004285684B2 (uk)
BR (1) BRPI0415636A (uk)
CA (1) CA2544352C (uk)
CO (1) CO5690641A2 (uk)
CY (1) CY1110339T1 (uk)
DE (1) DE502004010602D1 (uk)
DK (1) DK1682542T3 (uk)
EA (1) EA008587B1 (uk)
EC (1) ECSP066543A (uk)
ES (1) ES2338563T3 (uk)
HR (1) HRP20100029T1 (uk)
IL (1) IL175126A (uk)
ME (1) ME00349B (uk)
MX (1) MX272045B (uk)
MY (1) MY146628A (uk)
NO (1) NO20062569L (uk)
NZ (1) NZ547581A (uk)
PE (1) PE20050996A1 (uk)
PL (1) PL1682542T3 (uk)
PT (1) PT1682542E (uk)
RS (2) RS20060291A (uk)
SI (1) SI1682542T1 (uk)
TW (1) TWI336330B (uk)
UA (1) UA82909C2 (uk)
UY (1) UY28596A1 (uk)
WO (1) WO2005042527A1 (uk)
ZA (1) ZA200602344B (uk)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2606552A1 (en) * 2005-05-02 2006-11-09 Boehringer Ingelheim International Gmbh Crystalline forms of tiotropium bromide
CA2627729A1 (en) * 2005-12-19 2007-07-05 Sicor Inc. Novel forms of tiotropium bromide and processes for preparation thereof
RU2453547C2 (ru) * 2005-12-19 2012-06-20 Сикор Инк. Новые формы тиотропия бромида и способы их получения
US9108962B2 (en) 2005-12-19 2015-08-18 Sicor, Inc. Forms of tiotropium bromide and processes for preparation thereof
NZ570162A (en) * 2006-01-04 2011-09-30 Boehringer Ingelheim Int Use of tiotropium salts in the treatment of moderate persistent asthma which has the serverity of GINA step 3
CN100999521B (zh) * 2006-01-13 2010-12-08 江苏正大天晴药业股份有限公司 结晶性抗胆碱药噻托溴铵
US20080051582A1 (en) 2006-07-10 2008-02-28 Sicor Inc. Process for the preparation of tiotropium bromide
CN101032484B (zh) * 2007-04-02 2010-05-26 南京卡文迪许生物工程技术有限公司 一种噻托溴铵胶囊型吸入粉雾剂
GB0716026D0 (en) 2007-08-16 2007-09-26 Norton Healthcare Ltd An inhalable medicament
US20110250149A1 (en) * 2008-11-04 2011-10-13 Cipla Limited Tiotropium Bromide Having a Low Degree of Crystallinity
JP2012507574A (ja) * 2008-11-04 2012-03-29 シプラ・リミテッド 医薬エアロゾル組成物
US8697719B2 (en) * 2009-08-07 2014-04-15 Generics [Uk] Limited Anhydrate of tiotropium bromide
TR201111589A2 (tr) * 2011-03-03 2012-09-21 Bi̇lgi̇ç Mahmut Tiotropyum bromür susuz kristal formu.
CZ304368B6 (cs) 2011-11-28 2014-04-02 Zentiva, K.S. Směsný solvát tiotropium bromidu a způsob jeho přípravy
GB201200525D0 (en) 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
EP2897955B1 (en) * 2012-09-11 2019-11-06 Bilgic, Mahmut New tiotropium bromide crystalline form
KR20150079671A (ko) 2012-11-05 2015-07-08 젠티바, 케이.에스. 티오트로피움 용매화물을 안정화하는 방법
EP2913332A1 (en) 2014-02-27 2015-09-02 Euticals S.P.A. Crystalline form of tiotropium bromide with lactose
US10034866B2 (en) 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium
WO2017138896A1 (en) 2016-02-11 2017-08-17 Sima Patent Ve Lisanslama Hizmetleri Ltd. Şti Crystalline form of tiotropium bromide anhydrate
EP4108230A1 (en) 2021-06-24 2022-12-28 Laboratoires SMB New dry powder composition of tiotropium for inhalation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610163A (en) * 1989-09-16 1997-03-11 Boehringer Ingelheim Gmbh Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
EP1326862B1 (de) * 2000-10-12 2004-09-15 BOEHRINGER INGELHEIM PHARMA GMBH &amp; CO. KG Kristallines monohydrat von tiotropiumbromid, verfahren zu dessen herstellung und dessen verwendung zur herstellung eines arzneimittels
DE10111843A1 (de) * 2001-03-13 2002-09-19 Boehringer Ingelheim Pharma Verbindungen zur Behandlung von inflammatorischen Erkrankungen
KR100971616B1 (ko) * 2001-06-22 2010-07-22 베링거 잉겔하임 파르마 게엠베하 운트 코 카게 결정질 항콜린제, 이의 제조방법 및 이를 포함하는 약제학적 조성물

Also Published As

Publication number Publication date
PE20050996A1 (es) 2005-12-20
MY146628A (en) 2012-09-14
PL1682542T3 (pl) 2010-06-30
TW200526652A (en) 2005-08-16
ECSP066543A (es) 2006-10-17
NO20062569L (no) 2006-07-12
ZA200602344B (en) 2007-07-25
DK1682542T3 (da) 2010-05-10
BRPI0415636A (pt) 2006-12-12
DE502004010602D1 (de) 2010-02-11
KR101313904B1 (ko) 2013-09-30
SI1682542T1 (sl) 2010-04-30
RS51599B (sr) 2011-08-31
EA008587B1 (ru) 2007-06-29
HK1099752A1 (zh) 2007-08-24
AR046319A1 (es) 2005-11-30
KR101285571B1 (ko) 2013-07-15
CO5690641A2 (es) 2006-10-31
PT1682542E (pt) 2010-01-27
ATE453641T1 (de) 2010-01-15
MXPA06004940A (es) 2006-07-20
UY28596A1 (es) 2005-06-30
IL175126A (en) 2010-11-30
IL175126A0 (en) 2006-09-05
NZ547581A (en) 2009-03-31
JP2007509894A (ja) 2007-04-19
CN1875019A (zh) 2006-12-06
KR20060121131A (ko) 2006-11-28
UA82909C2 (en) 2008-05-26
CA2544352A1 (en) 2005-05-12
WO2005042527A1 (de) 2005-05-12
MX272045B (en) 2009-11-23
ME00349B (me) 2011-05-10
CY1110339T1 (el) 2015-01-14
CA2544352C (en) 2013-07-16
TWI336330B (en) 2011-01-21
KR20120036381A (ko) 2012-04-17
EP1682542A1 (de) 2006-07-26
JP4553902B2 (ja) 2010-09-29
EA200600853A1 (ru) 2006-10-27
MEP51708A (en) 2011-02-10
CN100509809C (zh) 2009-07-08
EP1682542B1 (de) 2009-12-30
ES2338563T3 (es) 2010-05-10
RS20060291A (sr) 2008-06-05
AU2004285684B2 (en) 2011-07-14
AU2004285684A1 (en) 2005-05-12

Similar Documents

Publication Publication Date Title
HRP20100029T1 (hr) Novi kristalinični anhidrid s antiholinergičkim učinkom
US5756483A (en) Pharmaceutical compositions for intranasal administration of apomorphine
ES2987493T3 (es) Comprimido oral desintegrable de edoxaban tosilato hidrato
RU2010124424A (ru) Фармацевтические композиции
PT998916E (pt) Composições medicamentosas para aplicação sobre as mucosas
JPWO2013125617A1 (ja) １−（３−（２−（１−ベンゾチオフェン−５−イル）エトキシ）プロピル）アゼチジン−３−オールまたはその塩を含有する固形医薬組成物
MX2013008314A (es) Tableta dispersable en forma oral.
NZ547523A (en) Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same
EP2005945A9 (en) Oseltamivir phosphate granule and preparation mehtod thereof
CN104000789A (zh) 一种阿德福韦酯分散片及其制备方法
WO2017077476A1 (en) Novel levothyroxine formulations for oral use
TWI826474B (zh) 包含二胺衍生物之顆粒劑、以及其用途及製造方法
CA2827299A1 (en) Liquid propellant-free formulation comprising an antimuscarinic drug
CN102626394A (zh) 一种精氨酸布洛芬颗粒剂及其制备方法
EP2566449B1 (en) Pharmaceutical compositions comprising ceftibuten
CN106361689A (zh) 一种福多司坦口服溶液及其制备方法
ES2343432T3 (es) Preparado granular que contiene un compuesto de biguanida.
RU2004132222A (ru) Порошковые композиции, пригодные для ингаляции
JPH10167958A (ja) ロキソプロフェンナトリウム類を含有する口腔内速溶性製剤及びその製造方法
KR100957731B1 (ko) 쓴맛이 저감된 프란루카스트 수화물을 함유하는 제제
PT97491B (pt) Processo para a preparacao de uma composicao farmaceutica, contendo nomeadamente um antibiotico beta-lactamico
JP2005526103A5 (uk)
TW201517934A (zh) 錠劑之製造方法
EP2566451A1 (en) Pharmaceutical compositions comprising cefditoren pivoxil
JP2001187735A (ja) 安定なニコランジル含有粉末の製造法